About the Editor

Professor Marry M. van den Heuvel-Eibrink, MD, PhD, is a senior consultant in pediatric oncology and hematology at the Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands, where she is responsible for the now established centralized care and translational research program for all children with renal tumors in the Netherlands. She is the current Chair of the European Working Group on Myelodysplastic Syndromes (EWOG-MDS) foundation, and the Dutch Childhood Oncology Group (DCOG) renal tumor committee. She is the co-chair of the International Society of Paediatric Oncology-Renal Tumour Study Group (SIOP-RTSG), steering committee member of the DCOG late effects consortium, and an active member of IBFM-AML study group. From 1997-2014 she was a senior consultant at the Erasmus MC-Sophia Children’s Hospital, Rotterdam. During this period, she was the Working Group leader of the Erasmus MC Postgraduate Molecular Medicine School, which is recognized by the Dutch Royal Academy of Science and Arts. Her major research interest is translational research in pediatric cancer, with a special focus on renal tumors, and the (genetic) variation of early and late childhood cancers. Professor van den Heuvel-Eibrink has published over 260 international peer reviewed manuscripts and is the supervisor of over 25 finalized and ongoing PhD projects.